INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹16 Cr | ₹17 Cr | ₹12 Cr | ₹12 Cr | ₹18 Cr |
What is the latest Total Current Liabilities ratio of INDO US BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹18 Cr |
How is Total Current Liabilities of INDO US BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | -6.44 | |
| Mar2024 | ₹17 Cr | 42.06 | |
| Mar2023 | ₹12 Cr | 0.70 | |
| Mar2022 | ₹12 Cr | -32.03 | |
| Mar2021 | ₹18 Cr | - | |
Compare Total Current Liabilities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹203.1 Cr | -0.2% | -1.4% | -31.2% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,623.6 Cr | -5.2% | -4.4% | -33.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,137.5 Cr | 0.7% | -0% | -6.7% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,042.4 Cr | 1.6% | 2.1% | 4.6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,025.8 Cr | 2.9% | NA | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹447.9 Cr | 3.8% | NA | 5.2% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -0.2% |
-1.4% |
-31.2% |
| SENSEX | 1.1% |
-2.1% |
-6.4% |
You may also like the below Video Courses